BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 32418883)

  • 1. Evaluation of length of stay after transfemoral transcatheter aortic valve implantation with SAPIEN 3 prosthesis: A French multicentre prospective observational trial.
    Durand E; Le Breton H; Lefevre T; Gilard M; Himbert D; Alcazar MU; Bettinger N; Auffret V; Didier R; Chevalier B; Béziau DM; Iung B; Eltchaninoff H
    Arch Cardiovasc Dis; 2020; 113(6-7):391-400. PubMed ID: 32418883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical outcomes after transcarotid and transsubclavian versus transfemoral transcatheter aortic valve implantation: A propensity-matched analysis.
    Villecourt A; Faroux L; Muneaux A; Tassan-Mangina S; Heroguelle V; Poncet A; Nazeyrollas P; Ruggieri VG; Metz D
    Arch Cardiovasc Dis; 2020 Mar; 113(3):189-198. PubMed ID: 32037133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcutaneous aortic valve implantation using the carotid artery access: Feasibility and clinical outcomes.
    Kallinikou Z; Berger A; Ruchat P; Khatchatourov G; Fleisch I; Korkodelovic B; Henchoz E; Marti RA; Cook S; Togni M; Goy JJ
    Arch Cardiovasc Dis; 2017; 110(6-7):389-394. PubMed ID: 28433509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
    Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
    J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcarotid Approach for Transcatheter Aortic Valve Replacement With the Sapien 3 Prosthesis: A Multicenter French Registry.
    Overtchouk P; Folliguet T; Pinaud F; Fouquet O; Pernot M; Bonnet G; Hubert M; Lapeze J; Claudel JP; Ghostine S; Azmoun A; Caussin C; Zannis K; Harmouche M; Verhoye JP; Lafont A; Chamandi C; Ruggieri VG; Di Cesare A; Leclercq F; Gandet T; Modine T
    JACC Cardiovasc Interv; 2019 Mar; 12(5):413-419. PubMed ID: 30772290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-Year Outcomes of Transfemoral Transcatheter Aortic Valve Replacement or Surgical Aortic Valve Replacement in a Real World Population.
    Barbanti M; Tamburino C; D'Errigo P; Biancari F; Ranucci M; Rosato S; Santoro G; Fusco D; Seccareccia F;
    Circ Cardiovasc Interv; 2019 Jul; 12(7):e007825. PubMed ID: 31284737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A feasibility study of transaxillary TAVI with the lotus valve.
    Doshi SN; George S; Kwok CS; Mechery A; Mamas M; Ludman PF; Townend JN; Bhabra M
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):542-549. PubMed ID: 29130619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of length of stay after transfemoral transcatheter aortic valve replacement: results from the FRANCE TAVI registry.
    Durand E; Avinée G; Gillibert A; Tron C; Bettinger N; Bouhzam N; Gilard M; Verhoye JP; Koning R; Lefevre T; Van Belle E; Leprince P; Iung B; Le Breton H; Eltchaninoff H
    Clin Res Cardiol; 2021 Jan; 110(1):40-49. PubMed ID: 32335689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study.
    Wood DA; Lauck SB; Cairns JA; Humphries KH; Cook R; Welsh R; Leipsic J; Genereux P; Moss R; Jue J; Blanke P; Cheung A; Ye J; Dvir D; Umedaly H; Klein R; Rondi K; Poulter R; Stub D; Barbanti M; Fahmy P; Htun N; Murdoch D; Prakash R; Barker M; Nickel K; Thakkar J; Sathananthan J; Tyrell B; Al-Qoofi F; Velianou JL; Natarajan MK; Wijeysundera HC; Radhakrishnan S; Horlick E; Osten M; Buller C; Peterson M; Asgar A; Palisaitis D; Masson JB; Kodali S; Nazif T; Thourani V; Babaliaros VC; Cohen DJ; Park JE; Leon MB; Webb JG
    JACC Cardiovasc Interv; 2019 Mar; 12(5):459-469. PubMed ID: 30846085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of patients at estimated low surgical risk undergoing transcatheter aortic valve implantation with balloon-expandable prostheses.
    Unzué L; García E; Teijeiro R; Antón BD; Del Río MR; Solís J; Alonso BR; Medina J; Rodrigo FJR; Parra FJ
    Cardiovasc Revasc Med; 2018 Apr; 19(3 Pt A):251-256. PubMed ID: 29030013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors, Incidence, and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation Complicated by Stroke.
    Vlastra W; Jimenez-Quevedo P; Tchétché D; Chandrasekhar J; de Brito FS; Barbanti M; Kornowski R; Latib A; D'Onofrio A; Ribichini F; Baan J; Tijssen JGP; De la Torre Hernandez JM; Dumonteil N; Sarmento-Leite R; Sartori S; Rosato S; Tarantini G; Lunardi M; Orvin K; Pagnesi M; Hernandez-Antolin R; Modine T; Dangas G; Mehran R; Piek JJ; Delewi R
    Circ Cardiovasc Interv; 2019 Mar; 12(3):e007546. PubMed ID: 30871358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally invasive versus transapical versus transfemoral aortic valve implantation: A one-to-one-to-one propensity score-matched analysis.
    Furukawa N; Kuss O; Emmel E; Scholtz S; Scholtz W; Fujita B; Ensminger S; Gummert JF; Börgermann J
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1825-1834. PubMed ID: 29861110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balloon expandable transcatheter aortic valve implantation via the transfemoral route with or without pre-dilation of the aortic valve - rationale and design of a multicentre registry (EASE-IT TF).
    Butter C; Bramlage P; Rudolph T; Jacobshagen C; Rothe J; Treede H; Kerber S; Frank D; Seilerova L; Schymik G
    BMC Cardiovasc Disord; 2016 Nov; 16(1):223. PubMed ID: 27846807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration.
    Vlastra W; Chandrasekhar J; Vendrik J; Gutierrez-Ibanes E; Tchétché D; de Brito FS; Barbanti M; Kornowski R; Latib A; D'Onofrio A; Ribichini F; Baan J; Tijssen JGP; Pan M; Dumonteil N; Mangione JA; Sartori S; D'Errigo P; Tarantini G; Lunardi M; Orvin K; Pagnesi M; Sanchez Gila J; Modine T; Dangas G; Mehran R; Piek JJ; Delewi R
    JACC Cardiovasc Interv; 2019 May; 12(10):911-920. PubMed ID: 31122347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis.
    Durand E; Eltchaninoff H; Canville A; Bouhzam N; Godin M; Tron C; Rodriguez C; Litzler PY; Bauer F; Cribier A
    Am J Cardiol; 2015 Apr; 115(8):1116-22. PubMed ID: 25726383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registry.
    Barbanti M; Baan J; Spence MS; Iacovelli F; Martinelli GL; Saia F; Bortone AS; van der Kley F; Muir DF; Densem CG; Vis M; van Mourik MS; Seilerova L; Lüske CM; Bramlage P; Tamburino C
    BMC Cardiovasc Disord; 2017 Oct; 17(1):259. PubMed ID: 29017461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral.
    Amat-Santos IJ; Rojas P; Gutiérrez H; Vera S; Castrodeza J; Tobar J; Goncalves-Ramirez LR; Carrasco M; Catala P; San Román JA
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):935-944. PubMed ID: 29314570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.